GLOBAL MYCOPLASMA TESTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Market Challenges And Opportunities

• High equipment costs: The high cost of instruments that is required for mycoplasma testing is a significant barrier impacting the expansion of the global mycoplasma testing market. Conducting mycoplasma testing involves procuring expensive equipment such as PCR systems, ELISA readers, microbial culture supplies, and others. These instruments have substantial initial purchase prices, ranging from tens of thousands to several hundred thousand dollars depending on the technique. Moreover, their annual maintenance and calibration costs are also steep. This heavy capital expenditure poses serious budgeting challenges for small and medium size laboratories and research facilities, especially in cost-sensitive developing markets. The high capital requirement limits their affordability and accessibility to perform mycoplasma testing on a regular basis as mandated by regulatory guidelines.

Counterbalance: To counter balance this restraint, market players need to reconsider all other viable factors before mentioning the cost of the equipment, thereby making the mycoplasma testing costs affordable.